Oric Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Oric Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • Oric Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $4.05M, a 97.9% increase year-over-year.
  • Oric Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $14.3M, a 142% increase year-over-year.
  • Oric Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $10.1M, a 281% increase from 2022.
  • Oric Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $2.65M, a 1596% increase from 2021.
  • Oric Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $156K, a 67.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.1M +$7.44M +281% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 $2.65M +$2.49M +1596% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 $156K -$327K -67.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $483K -$1.2M -71.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 $1.69M +$678K +67.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-21
2018 $1.01M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.